Intravascular coagulation activation in a murine model of thrombomodulin deficiency: Effects of lesion size, age, and hypoxia on fibrin deposition

Blood

Volumn 92, Issue 11, 1998, Pages 4188-4197

  Healy, Aileen M ^a   Hancock, Wayne W ^b   Christie, Patricia D ^b   Rayburn, Helen B ^b   Rosenberg, Robert D ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN DEPOSITION; GENE INACTIVATION; HYPERCOAGULABILITY; HYPOXIA; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0032402132     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4188     Document Type: Article

References (37)

1. Comp PC, Jacocks RM, Ferrell GL, Esmon CT: Activation of protein C in vivo. J Clin Invest 70:127, 1982
2. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou M-H, Samama MM, Rosenberg RD: Normalization of markers of coagulation activation with a purified protein C concentrat in adults with homozygous protein C deficiency. Blood 82:1159, 1993
3. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH: The frequency of Type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18, 1988
4. Esmon CT, Owen WG: Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78:2249, 1981
5. Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD: Human thrombomodulin gene is intron depleted: Nucleic acid sequence of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 84:6425, 1987
6. Boffa M-C, Burke B, Haudenschild CC: Preservation of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem 35:1267, 1987
7. Soff GA, Jackman RW, Rosenberg RD: Expression of thrombomodulin by smooth muscle cells in culture: Different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77:515, 1991
8. Ford VA, Wilkinson JE, Kennel SJ: Thrombomodulin distribution during murine development. Roux's Arch Dev Biol 202:364, 1993
9. Imada M, Imada S, Iwasaki H, Kume A, Yamaguchi H, Moore EE: Fetomodulin: Marker surface protein of fetal development which is modulatable by cyclic AMP. Dev Biol 122:483, 1987
10. Imada S, Yamaguchi H, Imada M: Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells. Dev Biol 141:426, 1990
11. Weiler H, Aird W, Rayburn H, Husain M, Rosenberg RD: Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 122:2271, 1996
12. Healy AM, Rayburn HB, Rosenberg RD, Weiler H: Absence of the blood clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 92:850, 1995
13. Thomas KR, Capecchi MR: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503, 1987
14. Mortensen RM, Conner DA, Chao S, Geisterfer AA, Seidman JG: Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 12:2391, 1992
15. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R: The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryo Exp Morph 87:27, 1985
16. Carrell N, McDonagh J: High resolution electrophoretic analysis of human fibrinogen and its crosslinked intermediates. Thromb Haemost 49:47, 1983
17. 125I-Fibrin deposition in contact sensitivity reactions in the mouse. Sensitivity of the assay for quantitating reactions after active or passive sensitization. J Immunol 136:2018, 1986
18. Bradley A: Production and analysis of chimaeras, in Robertson EJ (ed): Teratocarcinomas and Embryonic Stem Cells. Washington, DC, Oxford, 1987, p 147
19. Dvorak HF, Form DM, Manseau EJ, Smith BD: Pathogenesis of desmoplasia. J Natl Cancer Inst 73:1195, 1984
20. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA: Costimulatory function and expression of CD 40-ligand, CD 80 and CD 86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 92:850, 1996
21. Risau W, Sariola H, Zerwes H-G, Sasse J, Ekblom P, Kemler R, Doetschman T: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102:471, 1988
22. Wang R, Clark R, Bautch V: Embryonic stem cell-derived cystic embryoid bodies form vascular channels: An in vitro model of blood vessel development. Development 114:303, 1992
23. Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 71:1195, 1992
24. Ford VA, Stringer C, Kennel SJ: Thrombomodulin is preferentially expressed in Balb/c lung microvessels. Proc Natl Acad Sci USA 267:5446, 1992
25. Maruyama I, Bell CE, Majerus PW: Thrombomodulin is found oh endothelium of arteries, veins, capillaries and lymphatics and on syncytiotrophoblast of human placenta. J Cell Biol 101:363, 1985
26. Weiler-Guetler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 101:1983, 1998
27. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG: Inherited predisposition to thrombosis. Cell 72:477, 1993
28. Ohlin AK, Marlar RA: The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 85:330, 1995
29. Kumada T, Dittman WA, Majerus PW: A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 71:728, 1987
30. Aird WC, Edelberg JM, Weiler-Guetler H, Simmons WW, Smith TW, Rosenberg RD: Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 138:1117, 1997
31. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord J, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419, 1994
32. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD: Aging-associated changes in indices of thrombin generation and portein C activation in humans. J Clin Invest 80:1527, 1987
33. Kario K, Matsuo T: Lipid-related abnormalities in the elderly: Imbalance between coagulation and fibrinolysis. Atherosclerosis 103:131, 1993
34. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD: Hypercoagulability in centenarians: The paradox of successful aging. Blood 85:3144, 1995
35. Boland EJ, Liu YC, Walter CA, Herbert DC, Weaker FJ, Odom MW, Jagadeeswaran P: Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice. Blood 86:2198, 1995
36. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D: Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J Biol Chem 270:11463, 1995
37. Lawson CA, Yan SD, Yan SF, Liao H, Zhou YS, Sobel J, Kisiel W, Stern DM: Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 99:1729, 1997